Piper Sandler Adjusts Price Target on Intuitive Surgical to $490 From $435, Overweight Rating Kept
Intuitive Surgical Analyst Ratings
Intuitive Surgical (ISRG) Gets a Buy From Piper Sandler
Buy Rating Affirmed for Arrowhead Pharmaceuticals Amid Promising Plozasiran Developments
Arrowhead Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM), Legend Biotech (LEGN) and Intuitive Surgical (ISRG)
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Natera (NTRA) and Argenx Se (ARGX)
What 14 Analyst Ratings Have To Say About Stryker
Stryker Analyst Ratings
Intuitive Surgical Analyst Ratings
Boston Scientific Analyst Ratings
Evercore ISI Adjusts Price Target on Boston Scientific to $81 From $78, Maintains Outperform Rating
Evercore ISI Adjusts Price Target on Stryker to $365 From $370, Maintains Outperform Rating
Evercore ISI Adjusts Price Target on Intuitive Surgical to $425 From $385, Maintains In-line Rating
Deutsche Numis Remains a Hold on Boston Scientific (BSX)
Axogen Analyst Ratings
Raymond James Initiates Coverage On Axogen With Outperform Rating, Announces Price Target of $13
Guardant Health Analyst Ratings
Vertex Pharmaceuticals Analyst Ratings
Redburn Atlantic Initiates Vertex Pharmaceuticals at Buy With $545 Price Target